Ticker: PFE | Published: 2026-09-23
PFE drifts post-deal
After the recent HHS pricing deal pop, Pfizer is consolidating with low volatility as a Hold rating and overvaluation concerns cap fresh buying interest.
Sources: https://news.futunn.com/post/1000093311/bernstein-maintains-pfizer-pfeus-with-hold-rating-maintains-target-price, https://finance.yahoo.com/markets/stocks/articles/pfizer-pfe-stock-may-overvalued-